15 terminated. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Terminated 15 |
Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dupilumab De-escalation in Pediatric Atopic Dermatitis Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose - Atopic Dermatitis | Phase 4 | Terminated | Johns Hopkins University | 1 | 2024-04-01 | 2026-11-03 |
| Tralokinumab for Dupilumab Failures tralokinumab - Atopic Dermatitis | Phase 4 | Terminated | Psoriasis Treatment Center of Central New Jersey | 7 | 2023-09-11 | 2026-05-22 |
| The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. ruxolitinib cream - Atopic Dermatitis | Phase 4 | Terminated | Incyte Corporation | 47 | 2023-03-16 | 2025-12-19 |
| Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis Crisaborole 2%, Vehicle treatment, Accelerometry device for children - Atopic Dermatitis | Phase 4 | Terminated | Boston University | 72 | 2022-07-26 | 2025-03-14 |
| The Healthy Baby Bottoms Study Diaper care with Theraworx - Diaper Dermatitis | Phase 4 | Terminated | Linda Fu | 5 | 2020-03-12 | 2021-12-17 |
| Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis Dupilumab, Placebo - Atopic Dermatitis (AD) | Phase 4 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | 2018-07-25 | 2021-10-04 |
| A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD Crisaborole ointment, 2%, Hydrocortisone butyrate cream, 0.1%, Pimecrolimus cream, 1% - Atopic Dermatitis | Phase 4 | Terminated | Pfizer | 237 | 2018-04-27 | 2022-01-10 |
| Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study Stoss vitamin D, Daily vitamin D, Stoss placebo - Atopic Dermatitis | Phase 4 | Terminated | Murdoch Childrens Research Institute | 13 | 2017-10-16 | 2025-03-14 |
| A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal Triamcinolone 0.1% - Dermatitis, Atopic | Phase 4 | Terminated | University of California, San Francisco | 11 | 2014-12-01 | 2019-01-24 |
| Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis. Ciclosporin, Alitretinoin - Atopic Dermatitis | Phase 4 | Terminated | Technische Universität Dresden | 15 | 2010-11-01 | 2014-06-03 |
| Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis Dapsone gel, 5% - Dermatitis Herpetiformis | Phase 4 | Terminated | Vanderbilt University Medical Center | 1 | 2010-07-01 | 2017-12-14 |
| Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4) Cream (betamethasone diproprionate, clotrimazole, and gentamicin sulfate), Cream (betamethasone diproprionate and gentamicin), Cream (betamethasone diproprionate) - Dermatitis, Atopic, Eczema, Atopic | Phase 4 | Terminated | Organon and Co | 3 | 2009-07-01 | 2022-02-09 |
| Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children pimecrolimus active cream, placebo base cream - Atopic Dermatitis | Phase 4 | Terminated | Children's Hospital of Michigan | 18 | 2006-11-01 | 2008-12-18 |
| Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis Penicillin versus cefuroxim per os - Streptococcal Infections | Phase 4 | Terminated | University Children's Hospital Basel | 194 | 2005-10-01 | 2007-01-17 |
| Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification Pimecrolimus, Corticosteroid - Atopic Dermatitis | Phase 4 | Terminated | Novartis Pharmaceuticals | 1091 | 2003-10-01 | 2011-03-23 |
Dermatitis, Atopic (12) · Asthma (1) · Dermatitis Herpetiformis (1) · Diaper Rash (1) · Mandibulofacial Dysostosis (1) · Pruritus (1) · Skin Diseases, Eczematous (1) · Streptococcal Infections (1)
Skin Diseases (15) · Skin and Connective Tissue Diseases (15) · Immune System Diseases (13) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12) · Genetic Diseases, Inborn (12) · Hypersensitivity (12) · Hypersensitivity, Immediate (12) · Skin Diseases, Eczematous (12) · Skin Diseases, Genetic (12) · Autoimmune Diseases (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bone Diseases (1) · Bone Diseases, Developmental (1)
pimecrolimus (3) · crisaborole (2) · dupilumab (2) · Adrenal Cortex Hormones (1) · Alitretinoin (1) · Clotrimazole (1) · Cyclosporine (1) · Dapsone (1) · Gels (1) · Gentamicins (1) · Ointments (1) · Triamcinolone (1) · Zinc Oxide (1) · ruxolitinib (1) · tralokinumab (1)
Boston University (1) · Children's Hospital of Michigan (1) · Incyte Corporation (1) · Johns Hopkins University (1) · Linda Fu (1) · Murdoch Childrens Research Institute (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Novartis Pharmaceuticals (1) · Organon and Co (1) · Pfizer (1) · Psoriasis Treatment Center of Central New Jersey (1) · Technische Universität Dresden (1) · University Children's Hospital Basel (1) · University of California, San Francisco (1) · Vanderbilt University Medical Center (1)
United States (10) · Germany (2) · Switzerland (2) · Australia (1) · Italy (1) · Poland (1) · Sweden (1) · United Kingdom (1)
Joy Wan, MD MSCE (1) · Kevin C Thomas, PhD (1) · Kirsten P Perrett, MBBS (1) · Lisa A. Beck, MD (1) · Sarah Arron, MD, PhD (1) · Ulrich Heininger, MD (1) · Urs B Schaad, MD (1)
PMID 16680006, PMID 18385500, PMID 20070141, PMID 22805051, PMID 22920495, PMID 22951056, PMID 23374261, PMID 26598458
2009 (1), 2018 (1), U19AI117673 (1)